Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.57 Million ≈ $2.28 Million USD) by net assets (CN¥5.73 Billion ≈ $838.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Wuhan Easy Diagnosis Biomedicine Co Ltd to measure how much of total assets are equity-financed.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002932 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Eagle Point Credit Company Inc. NYSE:ECC	0.031x
Vinci Partners Investments Ltd NASDAQ:VINP	-0.012x
Fleetpartners Group Ltd AU:FPR	0.029x
YASHO INDUSTRIES ORD (BSE) NSE:YASHO	0.139x
Sikarin Public Company Limited BK:SKR	0.035x
Shenzhen Shengxunda Technology Co Ltd Class A SHE:300518	0.020x
Dada Nexus Ltd NASDAQ:DADA	0.009x
Jing Jin Electric Technologies Co Ltd SHG:688280	0.340x

Annual Cash Flow Conversion Efficiency for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

The table below shows the annual cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Wuhan Easy Diagnosis Biomedicine Co Ltd .

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.66 Billion ≈ $827.62 Million	CN¥-70.05 Million ≈ $-10.25 Million	-0.012x	+12.34%
2024-12-31	CN¥6.02 Billion ≈ $880.72 Million	CN¥-85.05 Million ≈ $-12.44 Million	-0.014x	-122.65%
2023-12-31	CN¥6.29 Billion ≈ $920.73 Million	CN¥392.50 Million ≈ $57.43 Million	0.062x	-89.47%
2022-12-31	CN¥6.77 Billion ≈ $990.93 Million	CN¥4.01 Billion ≈ $587.21 Million	0.593x	+49.86%
2021-12-31	CN¥2.85 Billion ≈ $417.06 Million	CN¥1.13 Billion ≈ $164.92 Million	0.395x	+22.57%
2020-12-31	CN¥1.11 Billion ≈ $163.14 Million	CN¥359.68 Million ≈ $52.63 Million	0.323x	+783.28%
2019-12-31	CN¥615.62 Million ≈ $90.08 Million	CN¥22.49 Million ≈ $3.29 Million	0.037x	-59.67%
2018-12-31	CN¥592.59 Million ≈ $86.72 Million	CN¥53.67 Million ≈ $7.85 Million	0.091x	-52.68%
2017-12-31	CN¥242.93 Million ≈ $35.55 Million	CN¥46.50 Million ≈ $6.80 Million	0.191x	-43.07%
2016-12-31	CN¥175.08 Million ≈ $25.62 Million	CN¥58.86 Million ≈ $8.61 Million	0.336x	-13.84%
2015-12-31	CN¥115.39 Million ≈ $16.89 Million	CN¥45.02 Million ≈ $6.59 Million	0.390x	+17.45%
2014-12-31	CN¥49.59 Million ≈ $7.26 Million	CN¥16.47 Million ≈ $2.41 Million	0.332x	-28.26%
2013-12-31	CN¥13.60 Million ≈ $1.99 Million	CN¥6.30 Million ≈ $921.32K	0.463x	-36.17%
2012-12-31	CN¥1.42 Million ≈ $208.28K	CN¥1.03 Million ≈ $151.10K	0.725x	+103.22%
2011-12-31	CN¥21.45K ≈ $3.14K	CN¥-482.90K ≈ $-70.66K	-22.514x	--

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$506.29 Million

CN¥3.46 Billion CNY

Market Cap Rank

#12002 Global

#3415 in China

Share Price

CN¥14.88

Change (1 day)

+1.85%

52-Week Range

CN¥13.85 - CN¥22.86

All Time High

CN¥49.58